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Abstract – The paper describes how the comprehensive surveillance of bovine spongiform encephalopathy
(BSE) and studies carried out on these data has enhanced our knowledge of the epidemiology of BSE.
Around 7 000 BSE cases were detected through the screening of about 50 million cattle with rapid tests
in Europe. It confirmed that the clinical surveillance had a poor capacity to detect cases, and also showed
the discrepancy of this passive surveillance eﬃciency between regions and production types (dairy/beef).
Other risk factors for BSE were being in a dairy herd (three times more than beef), having a young age at
first calving (for dairy cattle), being autumn-born (dairy and beef), and being in a herd with a very high
milk yield. These findings focus the risk on the feeding regimen of calves/heifers. Several epidemiological
studies across countries suggest that the feedborne source related to meat and bone meal (MBM) is the only
substantiated route of infection — even after the feed ban —, while it is not possible to exclude maternal
transmission or milk replacers as a source of some infections. In most European countries, the average
age of the cases is increasing over time and the prevalence decreasing, which reflects the eﬀectiveness of
control measures. Consistent results on the trend of the epidemic were obtained using back-calculation
modelling, the R0 approach and Age-Period-Cohort models. Furthermore, active surveillance also resulted
in the finding of atypical cases. These are distinct from previously found BSE and classified in two diﬀerent
forms based on biochemical characteristics; their prevalence is very low (36 cases up to 1st September
2007), aﬀected animals were old and some of them displayed clinical signs. The origin and possibility of
natural transmission is unknown.
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1. INTRODUCTION
In April 1985 the first case of a disease
was observed in Great Britain that would later
be described as BSE. It was characterised by
slowly progressive neurological disorders of
adult cattle [62], always lethal, with various
and inconstant clinical signs related to men-
tal status, sensation, posture and movement,
as well as body loss and reduced milk yield,
that were precisely described by Cranwell
et al. [22] and Wilesmith et al. [64]. Based
on pathology changes, that were character-
ized by brain stem grey matter vacuolisation
and scrapie associated fibrils, pathologists evi-
denced a spongiform encephalopathy [62] and
the first transmission to mice was published
in 1988 [35]. In an early stage, epidemiology
took an important part in the understanding of
the disease, through diﬀerent studies carried
out by Wilesmith et al. [64–66] that evidenced
the role of meat and bone meal (MBM) as the
major route of infection. This led to control
measures implemented in 1988 in the United
Kingdom (UK) and subsequently in the Eu-
ropean Union (EU) to reduce the exposure of
cattle to MBM. They had a great eﬀect in
decreasing the epidemic, which was strongly
observed in the UK [38], but were not fully
eﬀective in controlling the disease, so that fur-
ther measures were taken. In the nineties, mod-
elling studies were carried out on the British
data [4] that estimated retrospectively the size
of the epidemic and the key parameters of it,
such as the age at infection and the incuba-
tion time. In the ten years since the initial
modelling, new diagnostic tools have been de-
veloped and widely used in the EU; through a
comprehensive active surveillance, the disease
has been discovered in many countries, and a
large amount of work has been done by dif-
ferent teams in the field of epidemiology and
modelling.
The aim of this paper is to present how these
new data and further studies have enhanced
our knowledge of the epidemiology of BSE.
We explain how the wide use of screening
tests has changed our view of the descriptive
epidemiology of BSE, what was learnt con-
cerning risk factors and routes of infection,
and how the BSE epidemic behaved as a re-
sult of new control measures. Then we address
the question of atypical forms of BSE found
as a result of intensive surveillance and we
draw some provisional conclusions in relation
to surveillance and control of BSE for the fu-
ture.
2. PASSIVE AND ACTIVE SURVEILLANCE
FOR BSE
2.1. Passive surveillance
By the beginning of 2000, only 9 out of
25 countries that have now reported BSE
cases, had detected BSE cases in the domestic
cattle population1. This large increase in the
number of countries with reported BSE cases
since 2000 was mainly based on the introduc-
tion of an extensive active surveillance system.
While a passive surveillance system is based
on the reporting of clinical suspect cases to the
veterinary authorities by veterinarians, with
active surveillance, statistically representative
numbers of animals are identified from defined
target populations and these animals are tested
for the disease [28,61]. Before 2001, only pas-
sive surveillance was implemented in most of
these countries, which depended entirely on
the mandatory reporting of clinically suspect
cattle by farmers, veterinarians, and others in-
volved in handling cattle, and the follow-up of
these animals by government veterinary ser-
vices.
Passive surveillance in general is assumed
to be eﬀective whenever the disease is highly
contagious, has a short incubation period, and
the clinical signs are easy to recognise [28].
These characteristics are not fulfilled in the
case of BSE, where usually only one animal
per herd is aﬀected and the incubation period
is on average more than five years. Also, there
is a misconception that BSE is easy to recog-
nise, as the clinical signs of BSE in cattle
are variable, often subtle, and not pathog-
nomonic [11, 18, 44]. Additionally, the will-
ingness to report suspected cases of BSE was
1 European Commission (2002), Report
on the monitoring and testing of bovine
animals for the presence of bovine spongi-
form encephalopathy (BSE) in 2001,
http://europa.eu.int/comm/food/food/biosafety/bse/
bse45_en.pdf [consulted 2 April 2007].
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and is often low; this is due to low compensa-
tion for suspected and/or confirmed cases, to
the consequences of a positive diagnosis and
subsequent control measures, which are often
not considered to be reasonable by cattle own-
ers, and to the stigmatization of cattle owners
– especially if they have the first case in the
country. The quality of these passive surveil-
lance systems diﬀered from country to country
and the results were not easy comparable.
2.2. Active surveillance
Because results of passive surveillance did
not allow the true BSE prevalence to be esti-
mated, in January 1999, Switzerland initiated
an active, targeted surveillance scheme to en-
hance the detection of BSE cases in the adult
cattle population [27, 29]. In addition to the
passive surveillance system, all cattle in the
entire risk population (i.e., all cattle that have
died or been killed on farm or during transport,
fallen stock, and cattle sent to emergency/sick
slaughter) over 24 months of age were tested.
Additionally, approximately 3% of the total
number of adult cattle sent to routine slaughter
were randomly sampled and tested, to min-
imise diversion of suspected BSE cases to rou-
tine slaughter. In spring 2000, France initiated
also the testing of the risk population in sev-
eral regions considered at higher risk of BSE
given the results of passive surveillance [15].
Based on these results, the EU introduced ac-
tive screening in risk populations for BSE in
January 2001, and expanded the surveillance
to all cattle subject to routine slaughter over 30
months of age (in some countries also younger
animals) to be implemented at latest in July
20011.
Through the introduction of active surveil-
lance, countries which claimed for years to
have no BSE cases detected their first cases.
Furthermore the incidence per million cattle
alive increased significantly in countries which
had already detected BSE cases before the start
of active surveillance (Fig. 1). These unbi-
ased surveillance data showed that most EU
countries did indeed have a low incidence of
BSE, which was already indicated by the re-
sults of the geographical BSE risk assessment
(GBR)2. The GBR, which had been initiated
in 1998 to assess the risk of having BSE for
various countries as a basis for trade and food
safety, was in fact very eﬀective in estimat-
ing the BSE risk. Most countries that had been
assessed into category III (likely a low level
of BSE present) did indeed find at least a
few cases of BSE through the active surveil-
lance. From 2001 to 2005, a total of around
50 million cattle have been tested in the frame-
work of the surveillance program in the EU,
of which around 7 000 cases proved BSE-
positive (Tab. I)1,3 ,4 ,5,6. The youngest case of
BSE to date was found by passive surveillance
in the UK7 and was 20 months old. In the
framework of the active surveillance system in
the EU only two animals below 30 months of
2 Scientific Steering Committee (2000), Final
opinion of the scientific steering committee
on the geographical risk of bovine spongi-
form encephalopathy (GBR), http://europa.eu.int/
comm/food/fs/sc/ssc/out113_en.pdf [consulted 2
April 2007].
3 European Commission (2003), Report on
the monitoring and testing of ruminants for
the presence of transmissible spongiform en-
cephalopathy (TSE) in 2002: http://europa.eu.int/
comm/food/food/biosafety/bse/annual_report_2002
_en.pdf [consulted 2 April 2007].
4 European Commission (2004), Report on the
monitoring and testing of ruminants for the pres-
ence of transmissible spongiform encephalopathy
(TSE) in the EU in 2003, including the results of the
survey of prion protein genotypes in sheep breeds,
http://europa.eu.int/comm/food/food/biosafety/bse/
annual_report_tse2003_en.pdf [consulted 2 April
2007].
5 European Commission (2005), Report on
the monitoring and testing of ruminants for
the presence of transmissible spongiform
encephalopathy (TSE) in the EU in 2004,
http://ec.europa.eu/food/food/biosafety/bse/annual_
report_tse2004_en.pdf [consulted 2 April 2007].
6 European Commission (2006), Report on
the monitoring and testing of ruminants for
the presence of transmissible spongiform
encephalopathy (TSE) in the EU in 2005,
http://ec.europa.eu/food/food/biosafety/bse/annual_
report_tse2005_en.pdf [consulted 2 April 2007].
7 http://www.defra.gov.uk/animalh/bse/statistics/bse/
yng-old.html, [consulted 4 April 2007].
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Figure 1. Number of BSE cases in the European Union, 1989–2005. Source European Commission, 2002
to 2006. Reports on the monitoring and testing of ruminants for the presence of transmissible spongiform
encephalopathy (TSE) in the EU. http://ec.europa.eu/food/food/biosafety/bse/ [consulted 2 April 2007].
Table I. Number of bovines tested, BSE-positive and prevalence rate in the three surveillance
streams, 2001-2005. Source European Commission, 2002 to 2006. Reports on the monitoring and
testing of ruminants for the presence of transmissible spongiform encephalopathy (TSE) in the EU
(http://ec.europa.eu/food/food/biosafety/bse/ [consulted 2 April 2007]).
Total tested (2001–2005) Total positive (2001–2005) Prevalence rate (positive cases
per 10 000 animals tested)
Risk population* 6 258 687 3 525 5.6
Routine slaughter 43 677 464 1 110 0.3
Clinical suspects 15 048 2 320 1 541.7
Total 49 951 199 6 955
* Emergency slaughtered, animals with clinical signs at ante-mortem and fallen stock.
age (28 and 29 months) have been detected.
Outside the EU, the only country where young
cases of BSE have been observed is Japan [71],
with two cases with 21 and 23 months of age
found by active surveillance. However, there
are doubts, whether the two very young cases
were adequately identified and formally con-
firmed8.
Although the largest numbers of tested cat-
tle were healthy slaughtered cattle, the ma-
jority of positive cases occurred in the sus-
pected cases and risk populations [29, 47, 48].
On average throughout the EU, the likelihood
of finding BSE cases is more than 20 times
higher in the risk populations than in healthy
slaughtered cattle. Passive surveillance is the
8 EFSA (2005), Annex to the opinion of the scien-
tific panel on biological hazards on the assessment
of the age limit in cattle for the removal of certain
specified risk materials (SRM), The EFSA Journal:
1–21.
most eﬃcient stream — highest ratio posi-
tives/suspects —, however with all the limita-
tions discussed above.
Based on the success of the active surveil-
lance in Europe, countries on other conti-
nents have also initiated similar surveillance
activities with comparable results9,10 [5, 59].
Recommendations for BSE surveillance of
the OIE now also include active surveil-
lance11. For comparison of surveillance sys-
tems among countries, the OIE guidelines
9 http://www.aphis.usda.gov/lpa/issues/bse_testing/
test_results.html [consulted 2 April 2007].
10 http://www.agr.gc.ca/cb/index_e.php?s1=n&s2=
2004&page=n41230b [consulted 2 April 2007].
11 OIE (2005), Surveillance systems for bovine
spongiform encephalopathy, Appendix 3, 8, 4,
Terrestrial animal health code, World Organisa-
tion for Animal Health, http://www.oie.int/eng/
normes/mcode/en_chapitre_ 3.8.4.htm. [consulted
2 April 2007].
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assign ‘point values’ to each sample tested,
based on the subpopulation from which it was
collected — the lowest value is given for rou-
tine slaughter cattle, and the highest value for
clinical suspects — and the likelihood of de-
tecting infected cattle in that subpopulation —
based on the age of animals. All the samples
tested are valued according to this guideline
and added together. A given number of total
points, based on the number of adult cattle in
the country and the risk, must be reached to
ensure suﬃcient level of surveillance.
The introduction of active surveillance con-
firmed the assumed limitations of the passive
surveillance systems in identifying and re-
porting BSE cases. Based on the results of
active surveillance it could be demonstrated
that the case ascertainment and case report-
ing levels during the time of passive surveil-
lance were very low [20, 29]. It could be
demonstrated through retrospective investiga-
tions that more than half of the cases found
by active surveillance had displayed clinical
signs before death, either characteristic for
BSE or at least suﬃciently suggestive [18,29].
Also, comparing cases found by active and
passive surveillance during the same period of
time (passive surveillance takes place before
death/slaughter) showed biases in the type of
animals detected by passive surveillance, the
ability to detect beef cow cases being far less
eﬃcient than detection of dairy cases [33].
The results of this extended surveillance
program in most countries in Europe over
several years has enabled comparisons of the
prevalence and trend of the BSE epidemic.
Also within countries, the development of the
epidemic can be constantly analysed, risk fac-
tors can be more reliably assessed and predic-
tions of the numbers of future cases can be
undertaken.
3. RISK FACTORS AND ROUTES
OF INFECTION
3.1. Risk factors
As explained previously, biases due to clini-
cal surveillance have induced biased estimates
of some risk factors at the beginning of the
epidemics. The implementation of a com-
prehensive surveillance based both on clini-
cal (passive) surveillance and testing (active
surveillance) in most of the European coun-
tries since 2001 has enabled a more rigorous
analysis of risk factors for BSE.
For example, in both the UK and France it
has been identified that dairy cows have a risk
of BSE approximately three times higher than
that of beef cows, once confounding factors
such as age at culling or region of origin have
been accounted for [33, 45, 68]. This is simply
explained by a higher use of compound feed in
dairy farms. However, the diﬀerence in risk be-
tween dairy and beef cows is not as important
as expected if we consider the considerable
amount of compound feed fed to dairy cows
in lactation compared to the relatively small
amount of compound feed used for beef cows.
However, this is consistent with an infection
at a younger age, when diﬀerences in feeding
practices (apart from milk supply) are less im-
portant between dairy and beef cattle, at least
in the French context where it has been stud-
ied.
Diﬀerent studies carried out in the UK
showed that autumn-born dairy cattle appeared
to be at a higher risk of infection than spring-
born dairy cattle [12, 39, 62, 66]. This has also
been confirmed in a recent study carried out in
France, which showed that French dairy cows
born from July to September were at a higher
risk for BSE12. It is most likely that this diﬀer-
ence in risk between autumn and spring-born
cattle is due to a diﬀerential use of concen-
trates for calves depending on their season
of birth. The reason is that the winter period
requires feeding in stable, with forage and con-
centrates, instead of grazing outside. For beef
cattle, the same tendency was observed in the
French study12, with a higher risk for those an-
imals born in August and November, that are
supposed to be fed more concentrate feedstuﬀs
and at a younger age.
Further work on the issue of concentrates
and risk of infection has been performed by La
Bonnardière et al. [46], who investigated the
12 Sala C., Morignat E., Roy P. et al., Seasonality
of exposure of cattle to BSE in France, in Proc.
Prion 2006, Strategies, advances and trends towards
protection of society, Torino, Italy, 2006, p. 117
(RA-10).
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eﬀect of milk yield on the risk of BSE at the
farm level in France, since milk yield is highly
correlated with the feeding of concentrates for
dairy cattle. Accounting for the region of the
farm, the year at risk and the herd size, it was
found that only the relatively small group of
high-yielding herds (above 10 000 kg per lac-
tation on average) had a more than three-fold
higher risk than in the least intensive herds (be-
low 7 000 kg). There was no linear increase in
risk as a function of milk yield, because herds
from the intermediate classes with a broad
range of milk yields (from 7 000 to 10 000 kg)
and which accounted for 85% of the sample,
had adjusted odds ratios for milk yield that did
not diﬀer significantly. Another factor of in-
terest was the age at first calving, which was
found to be correlated to milk yield in that
the higher the yield, the younger the age; it
appeared that the age at first calving had a
specific eﬀect on the risk, irrespective of milk
yield.
The herd size could be linked to the risk
of BSE for two reasons: firstly, the probabil-
ity of at least one case in a given herd is
size-dependent, and secondly, there are possi-
ble herd-size dependent risk factors for BSE,
such as certain farming practices. It has been
shown in the UK and Ireland that the BSE in-
cidence per animal is higher in large herds,
which suggests specific feeding practices in
those herds [32, 37]. However, results are not
consistent in all studies. Another epidemiolog-
ical study, carried out in Northern Ireland, did
not find the existence of a herd size eﬀect [26].
La Bonnardière et al. [46] also concluded from
French data, that no herd size eﬀect could be
detected in addition to the strict mathematical
relationship between the number of cattle at
risk and their age structure, and the probability
of at least one case in a herd.
Many diﬀerent spatial studies conducted in
the last few years have found important dif-
ferences in risk depending on geographical
areas in a given country, even after account-
ing for confounding factors such as the pro-
duction type. These geographical diﬀerences
in risk have been observed in the UK [58],
Switzerland [30], France [2], Spain [3], and
Ireland [57]. It has also been shown that the
spatial risk has moved over time, with a birth-
cohort dependence [34]. This is likely to be
due to spatial heterogeneity in the sources of
infection within each country.
3.2. Routes of infection
In 1991 it became evident that the ban on
MBM in ruminant feed, implemented in July
1988 in the UK, was not totally eﬀective, as
cases began to occur in UK animals born af-
ter the feed ban (BABs). The occurrence of
the BABs attracted much speculation about the
natural transmission of BSE between cattle,
either maternally or horizontally, since both
maternal transmission and horizontal trans-
mission were considered to occur for scrapie
in small ruminants [40]. When a suﬃcient
number of BAB cases had occurred in 1993,
a case-control study was initiated in the UK
to investigate the possibility of horizontal and
maternal transmission [39]. This study found
rates of maternal transmission consistent with
the study results to range between 0 and 13%.
Most importantly, the case-control study in-
dicated that neither maternal nor horizontal
transmission could account for the majority
of cases in animals born after the feed ban.
Maternal transmission has also been found to
provide a possible explanation for only a mi-
nority of cases from several countries after
similar feed bans [41, 55], and from subse-
quent data from the UK [69]. Outside UK
no BSE in oﬀspring of BSE cases have been
found. Modelling studies using data from GB
have also shown that maternal transmission, if
it does occur, does so at a very low rate; as-
suming that maternal transmission occurs in
the last six months of the incubation period,
Donnelly et al. [31] found a rate of maternal
transmission of 0.7% (95% confidence inter-
val of 0, 4.0%). In the UK, the within-herd
incidence has decreased coincidentally with
the national incidence and there are a rela-
tively small number of herds that have had
a large number of cases and there is there-
fore no evidence of horizontal transmission of
BSE. The low within-herd incidence of herds
aﬀected with BSE is also evidence that hori-
zontal transmission does not occur.
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The reasons for the BAB cases, albeit at a
reduced level compared to animals born be-
fore the feed ban, started to be identified in
GB with analysis of the geographical varia-
tion in incidence. A geographical analysis of
the incidence of BAB cases showed a sta-
tistically significant correlation between the
cumulative incidence of BAB cases and the
ratios of both cattle to pigs and cattle to poul-
try [67]. The conclusion was that there was
an accidental cross-contamination of ingredi-
ents used for cattle feedstuﬀs and ruminant
protein which was present in the feed mills
for use in pig and poultry rations. Cross-
contamination between feed intended for pigs
or poultry and cattle feed could have occurred
at the feedstuﬀ factory, if feed lines for cat-
tle and feed for monogastric species were
not distinct, during the transport of feed or
on the farm, especially in mixed farms with
both cattle and pigs or poultry. The potential
for cross-contamination is heightened by the
potential for low-dose exposure causing infec-
tion; in an oral exposure study it was shown
that cattle could become infected by as little
as 1 mg of brain homogenate [63]. A statisti-
cally significant relationship between the pig
density in a region and BAB cases has also
been found in subsequent studies on both the
GB data [58] and for other countries includ-
ing Northern Ireland, France, Switzerland, and
Spain [1, 3, 26, 30, 55], supporting this ini-
tial hypothesis of cross-contamination of cattle
feed with feed intended for pigs, and possibly
poultry; a spatial study on feed factories con-
firmed recently the use of MBM in monogas-
tric feed as a risk factor for BSE [51]. Further
evidence on the BAB cases arising from the
feedborne source has been provided by Sheri-
dan et al. [57], where a spatial relationship
between feed-producers and BSE cases was
found. Recently, a case-control study [42] evi-
denced the use of feed from feedstuﬀ factories
fed to young cattle as well as the existence of
poultry operation in the farm, if using com-
pound feed, as risk factors for BSE, and thus
reinforced the role of compound feed in the
risk of BSE.
The removal of specified risk material
(SRM), which would contain the most in-
fectious material from cattle carcasses, from
MBM included in pig and poultry feed, has
not been found to completely remove the feed-
borne risk of exposure. Ducrot et al. [34] found
that cases born after such a ban in France
(BASBs) had a similar spatial distribution to
BAB cases, suggesting a common source of in-
fection. Similarly, Schwermer et al. [55] found
that the feedborne source was the most likely
route of infection for cases born after an SRM
ban in MBM (BAB96), although they consid-
ered imported feed or feed ingredients as the
most likely source of contaminated feed in
Switzerland. The lack of complete eﬀective-
ness of the SRM ban is likely to be due to
the diﬃculties of complete removal of some
tissues, and the possibility of residual risk in
production plants from earlier periods. In Ger-
many, the main routes of transmission have
been considered to be cross-contaminated ru-
minant concentrate feeds and milk replacers,
which contained animal fat [19]. In Bavaria,
60–75% of ruminant feed samples taken be-
tween 1996 and 2000 were contaminated with
animal material [19] and this contamination
could have led to exposure to BSE of ru-
minants. In Germany, milk replacers could
legally contain animal-derived fats until 2000,
and it is possible that either infectious material
survived the rendering process or that infec-
tious material entered milk replacers through
the use of unrefined fats, which were used in
milk replacers in Germany [43]. Pottgiesser
et al. [52] have also shown a possible asso-
ciation of the feeding of milk replacers with
BSE infection in the Schleswig-Holstein re-
gion of Germany; the use of milk replacer was
also found to be a risk factor in France [42],
and they have been suggested as a potential
route of infection in Denmark, where Pais-
ley and Hostrup-Pedersen [50] showed that
tallow-based milk replacers could have been
responsible for all seven cases of BSE in this
country. However, there is no experimental ev-
idence to show that tallow from an infected
cow contains infectivity, and so the link be-
tween milk replacers and BSE infection re-
mains a hypothesis.
BSE cases have continued to occur in the
UK after a ban on feeding any MBM to farm
(page number not for citation purpose) Page 7 of 18
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animals, which would have prevented cross-
contamination of MBM between monogastric
animals and cattle feeds. A preliminary epi-
demiological analysis of the first 16 cases
born in the UK after the imposition of this
ban found a spatial homogeneity of the risk
and hypothesized that the most likely source
of infection was the importation of feed in-
gredients that were contaminated with the
BSE agent [69]. There was potential for this
cross-contamination to occur during mechan-
ical handling, storage and transport of feed
ingredients imported into the UK with mam-
malian MBM legitimately imported for other
purposes. Exposure from an environmental
non-feed source was considered unlikely due
to the absence of previous clinical cases on
four of the aﬀected farms [69].
In conclusion, epidemiological evidence
across several countries suggests that the feed-
borne source related to MBM is the only
substantiated route of infection, while it is not
possible to exclude maternal transmission or
milk replacers as a source of some infections.
The majority, if not all, of the cases born af-
ter the ban on MBM in ruminant feed have
arisen due to continued exposure to contami-
nated feed.
4. CONTROL MEASURES AND
EVOLUTION OF THE BSE EPIDEMICS
4.1. Evolvement of control measures
The history of the BSE epidemic has pro-
vided a considerable amount of information on
the eﬃcacy of control measures for BSE. Af-
ter detecting the first BSE case, it took the UK
less than two years (i.e., less than half of the
incubation period) to realise that there was a
major new infection in their cattle population,
and to identify the major route of transmission.
In the summer of 1988 the first ban on the use
of ruminant MBM in ruminant feed was intro-
duced, soon followed by a specified risk ma-
terial/specified bovine oﬀal (SRM/SBO) ban
in September 1990. This led to a continuously
decreasing infection pressure in the birth co-
horts since autumn 1988. Two conclusions can
be drawn from this. Firstly this leads to the
conclusion that these initial control measures
were suﬃcient to control the epidemic, even if
not fully eﬃcient; i.e., the transmission was re-
duced suﬃciently for the number of infections
in subsequent birth cohorts to fall. Secondly,
BSE mainly infects the young stock, other-
wise the eﬀect on the 1988 cohort could not
have been so pronounced, as earlier cohorts
would also have been aﬀected. In mainland
Europe an understanding of the risk of in-
fection through MBM was learned with some
delay, but imports of MBM from the UK were
soon considered an important risk factor after
BSE cases were found in Switzerland. Individ-
ual countries did implement control measures
to limit the imports and use of MBM for
ruminants, and EU-wide ban on the use of
mammalian MBM for ruminants was imple-
mented in 1994, although enforcement of this
ban was clearly a problem in several countries.
In 1996 the first article on the zoonotic as-
pect of BSE was published [70], followed by
publications estimating the possible size of
the human epidemic as a result of the expo-
sure to BSE. Given the limited data at that
time, and the uncertainty in the human incu-
bation period and the eﬀect of the SBO ban
(implemented for human food in the UK in
1988), the predicted size of the epidemic var-
ied significantly and included predictions that
100 000 UK citizens could be infected by
BSE and would develop the disease within
20 years time [21], while others predicted
less than one million [36]. The resulting crisis
amongst consumers caused further inspection
of control measures and a study of the com-
pliance. The UK extended their ruminant feed
ban, to further restrict possibilities for cross-
contamination in feed production, in an at-
tempt to completely halt further transmission.
In the meantime, research showed that render-
ing systems can reduce the infectious level in
MBM, if they apply pressurized cooking at
suﬃciently high temperature [54]. However,
this measure does not remove all infectivity; it
only reduces the infectious load in the material
up to a thousand times, whereas the systems
applied in the UK in the 1980s were consid-
ered to reduce the infectious load by at most
a factor 10. The EU implemented the batch
process (133 ˚C at 3 bars during 20 min) as
a standard for rendering systems in 1996, but
Page 8 of 18 (page number not for citation purpose)
Epidemiology and dynamics of BSE epidemics Vet. Res. (2008) 39:15
implementation was slow in some member
states due to practical problems and failure to
see BSE as a domestic problem.
BSE cases still occurred in the UK after
the implementation of the ban on the feeding
of mammalian MBM for all farmed animals,
known as cases that were born after the re-
inforced ban (BARBs). While it was evident
that the number of cases in the BARB co-
horts in the UK had declined as a result of
this control measure, the continued occurrence
of these cases led to such pressure on policy
within the UK and the EU, that in January
2001 the EU also implemented a total ban on
the use of MBM to all farmed animals, as well
as a ban on other by-products.
4.2. Evolution of the BSE epidemic analysed
from modelling and age of cases
During the BSE epidemic new control mea-
sures were introduced regularly, and only a
few minor aspects of the measures were later
lifted due to being considered ineﬀective. The
eﬀect of BSE control measures can be seen
from the surveillance data by studying the age
distribution per test year and per birth cohort.
First of all, it can be shown that the mean age
of BSE cases per test year increases over time,
which is a direct result of the extended control
measures. Each set of control measures leads
to a specific transmission level of the infec-
tion. The number of new cases resulting from
an initial infection can be expressed in the ba-
sic reproduction ratio, R0, [24]. A R0 of 1 tells
us that one infected animal gives rise to (on av-
erage) one new infected animal. When the R0
is above 1, each new infection results in more
than one infection so the epidemic increases.
Similarly, a R0 below 1 is linked to a decrease
of an epidemic.
Each value of R0 induces a specific age
distribution of the cases in a test year [25].
This knowledge can be used to evaluate the ef-
fect of control measures and to compare the
progress of the epidemic in various countries.
Obviously this aspect is influenced by the age
distribution of the cattle population; however,
by comparing the age distribution of cases per
test year to the age distribution per birth co-
hort, this aspect becomes irrelevant. If the age
distribution of cases per cohort is equal to the
age distribution of cases per test year, then
it can be concluded that the epidemic is not
growing, nor declining (R0 ≈ 1). When the age
distribution of the cases per test year is show-
ing a greater tendency for younger cases than
the age distribution per birth cohort, then it can
be concluded that the epidemic is still growing
(R0 > 1), and vice versa. This is explained in
more detail by de Koeijer et al. [25].
Due to this eﬀect, the analysis of the aver-
age age of the cases year after year is simple
and gives an indication of the trend of the
epidemic [53]. Roughly, if the average age is
increasing, it corresponds to a decreasing R0,
and when the average age of the cases per
test year is higher than the average age in a
cohort, that means that R0 < 1, i.e., a declin-
ing of exposure over time. The method and
the conclusions are straightforward if the as-
sumptions are correct (e.g., steady values for
surveillance and age dependant culling of the
cattle population, age at infection and incuba-
tion period). The average age of BSE cases is
increasing over time in most European coun-
tries (Tab. II), which reflects their improving
BSE control systems over the years. There is a
delay in the appearance of this pattern due to
the long incubation period of BSE and its large
variance; we can see from the UK data that the
eﬀect of the control measures from 1988 and
1989 led to an increasing average age of the
BSE cases from year 1991 onwards. We can
see the age distribution of the cases stabilize
around 1993 but it soon increases further due
to extra control measures implemented during
the 1990s.
The mechanistic models that describe the
BSE epidemic rely heavily on the assumptions
made, of which a number cannot be validated
by an external measure for BSE (e.g., dis-
tribution of the age at infection, or level of
surveillance in the past). However, they pro-
vide estimates of the eﬀect of missing data
(e.g., cattle still alive), prevalence and past
transmission risk, and can therefore quantify
the eﬀect of control measures. The R0 ap-
proach [24] was applied to British, Dutch,
and Swiss data [55], and showed the eﬀect
of the ban of MBM to ruminants, and more
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interestingly provided evidence for an exter-
nal infection source (imports of MBM) that
was not considered in the model, and which
is therefore to be investigated separately.
4.3. Evolution of the BSE prevalence over years
Having the best unbiased estimate of the
prevalence of BSE and its trend in time is of
the highest importance for risk managers to as-
sess the eﬃciency of control measures and also
to contribute to the evaluation of the risk for
animals and humans. The crude analysis of the
figures of the BSE epidemics shows huge dif-
ferences between countries. By 2007, BSE had
been detected in 25 countries, the number of
cases per country ranging from 1 to more than
180 000 cases13. When considering the ten
most aﬀected countries (Tab. II and Fig. 2), the
pattern of the epidemic diﬀers dramatically be-
tween countries. The strong diﬀerences in the
number of cases and the prevalence rate may
reflect large diﬀerences in the level of expo-
sure of the cattle population and the eﬃciency
of control measures in the diﬀerent countries
(it also relates to variations of the level of
surveillance in Europe before 2001). Also, the
diﬀerences in the year of detection of the first
case and the year of the peak evoke variable
time-dependent exposure patterns. But above
all, from a simple look at the figures, data sug-
gests that the epidemic is now under control,
at least in countries which have experienced
the disease, taken stringent measures of con-
trol and seriously monitored the disease.
Beyond the crude analysis of figures, it is
diﬃcult to estimate precisely the size and trend
of the epidemic in any country without knowl-
edge of the characteristics of the disease, the
demographic parameters of the cattle popu-
lation, and the performances of the current
diagnostic methods. The age at which the dis-
ease becomes detectable is higher than the age
at which most animals die or are slaughtered,
the time from infection to detection is poorly
documented, and there is no diagnostic test on
live cattle so far. Moreover, until 2001 in the
EU and still now in most other countries of the
13 http://www.oie.int/eng/info/en_esbmonde.htm
[consulted 2 April 2007].
world, the incidence was/is heavily underes-
timated without active surveillance programs
carried out on suﬃcient sample sizes. Even
in EU countries having implemented a com-
pulsory testing at fallen stock and slaughter
since 2001, the hindsight is still limited and
hampers the estimate of the recent trend of
the disease; none of the birth cohorts has
been completely tested after six years of ex-
haustive testing. A correct assessment of the
prevalence and its trend needs to take into ac-
count all these parameters. Diﬀerent methods
have been applied, from the statistical analysis
of surveillance data including logistic regres-
sions and Age-Period-Cohort (APC) models,
to mathematical modelling of surveillance data
including back-calculation models and R0 ap-
proaches (see previous paragraph).
The statistical analysis of the surveillance
data using logistic regression is relevant when
comparing a few successive birth cohorts dur-
ing a period in which the surveillance is con-
sidered to be steady, and gives estimates of the
trend of prevalence from one birth cohort to
the next (odds ratios which can be considered
as relative risks due to the low prevalence).
This method was applied to French data [45]
and provided evidence of a major decrease of
the exposure between birth cohorts 94–95 and
95–96 for slaughtered animals (OR = 0.46,
95% CI 0.27-0.78). If the assumption of a
steady surveillance is not fulfilled, the changes
in the surveillance must be taken into account,
which is possible using an APC model. Based
on logistic or Poisson regression, it allows the
estimation of the trend of prevalence (the co-
hort factor) taking into account the age of
cases and the year of detection (the period fac-
tor). Applied to Swiss data, the APC model
identified a major drop of incidence after birth
cohort Oct. 89–Mar. 90, which was interpreted
as the eﬀect of the feed ban of 1990, and
then a second but less important incidence
peak for birth cohort Apr.–Sept. 94, which
could be the result of cross contamination with
contaminated feed dedicated to non-ruminant
species [20]. These statistical models, logis-
tic regression and APC models enable other
variables that are linked to the prevalence to
be taken into account, such as the production
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Figure 2. BSE trend in the top ten most aﬀected countries in Europe (UK excluded).
Incidence (per million cattle over 24 months) from 1989 through 2006. Source OIE
(http://www.oie.int/eng/info/en_esbmonde.htm, [consulted 2 April 2007]).
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type [33] or the season of birth12, and then
remove these confounders in the estimate of
the trend of prevalence. The major drawback
of APC model is that the three factors are lin-
early linked. It is therefore over-parametrized
and need further assumptions to disentangle
the three factors (e.g., equalizing arbitrarily
certain parameters or assuming a function for
the level of surveillance over time). Back-
calculation models have been used on the same
data [60] and gave results consistent with the
statistical analysis [16].
5. ATYPICAL BSEs AND THEIR
EPIDEMIOLOGICAL MEANING
The huge increase of the BSE active
surveillance programs in Europe, Northern
America, and Japan, and the refinement of the
diagnostic methods, mainly the biochemical
ones, led to the identification at the dawn of
the third millennium of two novel forms of
TSEs in cattle, named atypical BSEs. BSE has
long been considered to be a disease caused by
a unique infectious agent. In particular, PrPres
associated with the disease showed unique
biochemical features in cattle whatever the
country of origin of the case, as well as af-
ter experimental transmission to rodent models
or natural transmission to other species includ-
ing humans. However, recent studies reported
cases in cattle showing diﬀerent PrPres fea-
tures when compared to classical BSE. These
cases are of two diﬀerent types: (i) a H-type
that was first described in France [9], charac-
terized by a higher apparent molecular mass
of unglycosylated PrPres; (ii) a bovine amyloid
spongiform encephalopathy (BASE) that was
first described in Italy on two animals [17].
These two cases were able to be more deeply
studied, because the entire brain was available,
showing significant diﬀerences in the distri-
bution of the brain lesions, with the presence
of amyloid plaques that led to the proposal
of the term BASE. They were characterized
by a lower apparent molecular mass of ung-
lycosylated PrPres and lower levels of digly-
cosylated PrPres, sharing these characteristics
with a L-type form described later in other
countries. Other biochemical diﬀerences char-
acterize these atypical forms depending on
the antibody used. These two atypical forms
can also be diﬀerentiated from each other as
well as from classical BSE, using Fisher dis-
criminant analysis [49] that specified which
antibodies were the most relevant to identify
the atypical forms.
The two forms of atypical BSE have
been successfully transmitted to rodent mod-
els. More precisely, transmission of H-type
in wild-type mice (C57Bl6) showed that
the molecular features were maintained in
mice [7], and transmission of H-type in trans-
genic mice expressing bovine or ovine PrP
showed features clearly distinct from that of
classical BSE as well as sheep scrapie isolates
passaged in these models so far [8]. Transmis-
sion of L-type in other bovine PrP transgenic
mice led to an incubation period significantly
shorter than that found with classical BSE
and showing distinct biochemical characteris-
tics [14]. Experimental transmission of the two
types to cattle has been initiated recently14 and
results will be of the utmost interest.
Cases of atypical BSE have only been found
in countries having implemented large active
surveillance programs. As of 1st September
2007, 36 cases (16 H, 20 L) have been de-
scribed all over the world in cattle: Belgium
(1 L) [23], Canada (1 H)15, Denmark (1 L)16,
France (8 H, 6 L)17, Germany (1 H, 1 L) [13],
Italy (3 L)18, Japan (1 L) [71], Netherlands
(1 H, 2 L)19, Poland (1 H, 6 L)20, Sweden
14 Buschmann A., Gretzschel A., Biacabe A.G.
et al., Characterization of atypical BSE cases of
the H-and L-type in Germany, in Proc. Prion 2006,
Strategies, advances and trends towards protection
of society, Torino, Italy, 2006, p. 195.
15 http://www.inspection.gc.ca/english/anima/heasan/
disemala/bseesb/mb2006/6investe.shtml [consulted
2 April 2007].
16 L. Paisley, personal communication.
17 A.G. Biacabe, personal communication.
18 G. Ru, personal communication.
19 J. Langeveld, personal communication.
20 M. Polak, personal communication.
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(1 H)21, United Kingdom (1 H)22, and USA
(2 H)23. Another H-type case has been found
in a 19 year old miniature zebu in a zoologi-
cal park in Switzerland [56]. It is noteworthy
that atypical cases have been found in coun-
tries that did not experience classical BSE so
far, like Sweden, or in which only few cases of
classical BSE have been found, like Canada or
the USA.
Most of atypical cases have been found in
adult and old animals, with the striking ex-
ception of the Japanese case aged 23 months,
which would be worth deeper investigation8.
Apart this case, the age of the cases ranged
from 6.3 to 18 years, with an average of 11.8
and 11.6 years for H and L-type forms respec-
tively. However it is very diﬃcult to estimate
precisely the age distribution of the atypical
cases, because there are very few cases and
the search for these cases has been focused
retrospectively on the oldest BSE cases, for
example in Germany and partly in France.
Anyway, when properly investigated, it ap-
pears that the atypical cases are significantly
more frequent in cattle over eight years24.
Eighteen atypical cases out of the 35 detected
have been found through the abattoir stream of
surveillance, and therefore in animals assumed
to be healthy, even if it has been demonstrated
in France that part of the classical BSE cases
detected at the slaughterhouse had shown clin-
ical signs compatible with BSE [18]. The other
19 atypical cases have been detected in fallen
stock or in emergency slaughtered animals:
four of them have been described as diseased,
recumbent or downer cow before death, and
three others in France had shown clinical signs
compatible with a TSE, according to the ret-
rospective interview of the farmer and veteri-
narian. This was also the case for the zebu in
Switzerland that was precisely monitored be-
fore death. Therefore, it seems that at least part
21 Gavier-Widén D., Renstöm L., Nöremark M.
et al., Characterization of an atypical type-H BSE
case in Sweden, Conference Neuroprion, 2006.
22 http://www.fwi.co.uk/Articles/2007/03/09/102241/
uks-first-case-of-h-type-bse-confirmed-by-defra.
html [Consulted 2 April 2007].
23 J. Richt, personal communication.
24 E. Morignat, personal communication.
of the atypical cases could have been clinically
aﬀected when detected, but much remains to
be looked at in this field. The prevalence of
atypical BSE appears to be very low in ev-
ery country in which cases have been found.
For example in France, the search for atypical
has been carried out exhaustively on cases de-
tected since 1st January 2003, and only eight
atypical cases have been found as of 10th
March 2007, for more than 11 million animals
tested. However, due to the very low number
of cases and bias in the investigation of the
atypical cases among test positive animals, it
is impossible to compare prevalence between
countries.
So far, the origin of these novel forms of
TSE remains totally unknown. Several hy-
potheses have been raised [6], such as a major
change of the BSE agent, another source of
TSE such as sheep and goat scrapie, or a previ-
ously unrecognised form of TSE in cattle; also
beyond these hypotheses, the question arises
whether these cases are due to exposure to a
TSE agent or are a ‘spontaneous’ form of TSE.
Apart from the Japanese case born in 2001, all
the cases detected so far were born before the
total ban of MBM in feed of farm animals (the
year of birth ranged from 1987 to 1999) and
therefore it is too early to exclude an expo-
sure through contaminated feed. Considering
that the compulsory testing of cattle started in
2001 in Europe, and that atypical BSEs are
found in animals aged more than six years,
one cannot exclude the possibility of finding
cases born after 2001 in the future. And last
but not least, similarities of PrPres between H-
type BSE and human prion diseases like CJD
or GSS have been put forward [10], as well
as between L-type BSE and CJD [17]. These
findings raise questions about the origin and
inter species transmission of these prion dis-
eases that were discovered through the BSE
active surveillance.
6. CONCLUSION
In the last ten years, a considerable amount
of active surveillance data has been collected.
An important outcome from the analysis of
these data for several EU countries, confirming
the initial findings in the UK, is the diﬃculty
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of completely eradicating the risk of feed-
borne exposure. MBM has still probably been
involved in cases born after the ban and re-
inforced ban of MBM in cattle feed. It has
also provided data with which to analyse the
trend of the BSE epidemic following control
measures. Some other important points arise
from these results in terms of surveillance
and control of BSE. First of all this overview
shows that there are a few control measures
which may have a major eﬀect on the con-
trol of BSE: (1) restrict MBM in ruminant
feed, especially for young cattle; (2) control of
cross-contamination between monogastric and
ruminant feed; (3) remove the materials with
the highest infectious load from food (food
safety measure) and feed (BSE control mea-
sure); (4) use high temperature pressurized
rendering systems (however, UK managed the
epidemic without this fourth measure, and it
has not been possible to specifically measure
its eﬀect on the BSE epidemic from the case
data).
Also, there is a simple method to assess the
national BSE situation: based on the age distri-
bution of the BSE cases found, one can assess
the eﬃciency of the control system. When the
age distribution of BSE cases in a test year is
shifted to older ages as it is in the birth cohort
distribution, then the epidemic is fading out.
Given the present low levels of BSE incidence
and the presence of SRM measures for food
safety, we can relax under those conditions.
However, when the age of the BSE cases is
younger than expected, the surveillance should
be intensified and a more thorough analysis
of the BSE control measures is warranted.
This will include the inspection of the imports,
especially for those countries that have com-
mercial contacts with countries with higher
BSE incidence.
And finally, to substantially reduce trans-
mission for eradication of a present BSE epi-
demic, a combination of these control mea-
sures is needed, but to prevent a new epidemic
when import risks are restricted, one could
even suﬃce with only one of these measures,
when they are fully enforced, or possibly a
combination of two2 [24]. This is based on a
quantitative analysis that showed that a well
enforced control measure should be able to re-
duce transmission levels or risk by 99%. Given
that the worst epidemic of any disease ever
seen had a reproduction ratio between 10 and
20, and the impact of all control measures
is more or less linear, this level of reduction
should prevent epidemics. However, this does
not suﬃce for eradicating an epidemic which
has developed already; and this also assumes
that the BSE risk in imports is less than the
internal risk of BSE transmission within the
country.
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